The potential of 4D’s approach in curbing antimicrobial resistance among bacterial pathogens

  14 September 2022

This article intends to collate and discuss the potential of 4D’s (right Drug, Dose, Duration and De-escalation of therapy) approach to tackle the emerging problem of AMR. For this, we searched PubMed, Google Scholar, Medline, and clinicaltrials.gov databases primarily using the keywords “optimal antibiotic therapy”, “antimicrobial resistance”, “higher versus lower dose antibiotic treatment”, “shorter versus longer duration antibiotic treatment”, “de-escalation study” and “antimicrobial stewardship measures” and based on the findings, form and expressed our opinion.

Further reading: Taylor & Francis Online
Author(s): Lovnish Thakur et al
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!